GLIMESTAR M 1 MG (Glimepiride (1 Mg) + Metformin (500 Mg))

Glimestar M1 Tablet is indicated for the management of type 2 diabetes mellitus. This medication combines two active ingredients: Glimepiride and Metformin. These components work synergistically to effectively reduce elevated blood sugar levels. Glimepiride enhances the secretion of insulin from the pancreas, while Metformin contributes by decreasing glucose production in the liver and improving insulin sensitivity in peripheral tissues. This combination therapy is typically considered when lifestyle modifications, such as diet and physical activity, prove insufficient in achieving glycemic control. It is crucial to adhere to the prescribed dosage and timing; it is recommended to take the tablet after meals to optimize its absorption and efficacy. Regular follow-up with your healthcare provider is essential, as they may adjust the dosage based on your ongoing blood sugar monitoring and response to treatment. Prior to initiating therapy, inform your healthcare provider of any pre-existing medical conditions or other medications you may be taking. Should you experience any adverse effects during treatment, it is important to report these to your healthcare provider without delay. For the best therapeutic outcomes, it is necessary to continue the medication for the duration specified by your doctor. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.